BuSpar Antitrust Suit Will Test Theory Of “Orange Book” Abuse

A multi-state antitrust suit against Bristol-Myers Squibb over the BuSpar patent challenge will test the theory that some manufacturers are abusing the "Orange Book" patent listing process